Neuroprotective Role of Synthetic Peptide DP1 in Reducing Inflammation‐Associated Brain Damage and Cognitive Impairments
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202501139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Sheetal Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics, Panjab University, Chandigarh, India. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Neuroprotective Agents, Inflammation, Peptides. Die Arbeit nennt 47 Literaturangaben. Gefördert von: DRDO, UGC-BSR, UGC-SAP.
Abstract (Originalsprache)
Neuroinflammation serves as a central process in the development of various neurodegenerative diseases, often triggered by systemic inflammation. Within the realm of current scientific investigation, there is considerable interest in antimicrobial peptides (AMPs) due to their versatile attributes, extending beyond their traditional antimicrobial functions, encompassing significant anti‐inflammatory properties. Among these, the novel peptide DP1 stands out as an example, exhibiting antimicrobial and anti‐inflammatory properties. This study evaluates the anti‐inflammatory potential of DP1 against lipopolysaccharide (LPS)‐induced neuroinflammation in rats. Neuroinflammation was induced via intraperitoneal (ip) injection of LPS (1 mg/kg body weight), followed by DP1 treatment (1.25 mg/kg body weight) in adult male Sprague Dawley rats. The alteration in the brain was monitored by biochemical, behavioral, histopathological, and immunohistochemical analysis. LPS‐induced cognitive deficits were significantly improved by DP1 administration. Biochemical alterations and neuroinflammatory markers, including microglial and astrocytic activation, were restored to normal levels following DP1 treatment. Histopathological analysis confirmed reduced neurodegeneration. In conclusion, our results showed that DP1 inhibited LPS‐induced microglial and astrocytic activation, restored the extent of neurodegeneration in different regions of the rat brain, thereby mitigating neuroinflammation as well as neuroinflammation‐induced learning and memory deficits in rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics, Panjab University, Chandigarh, India.
- University School of Allied Health Sciences, Rayat Bahra University, Mohali, India.
ORCID-Profile: Mayank Maan, Shubhi Joshi, Panchali Barman, Avneet Saini
Förderung
- DRDO
- UGC-BSR
- UGC-SAP
- DST-FIST
- Defence Research and Development Organisation
Zitieren
APA
Sharma, S., Rai, P., Maan, M., Joshi, S., Barman, P., Sharma, S., & Saini, A. (2026). Neuroprotective Role of Synthetic Peptide DP1 in Reducing Inflammation‐Associated Brain Damage and Cognitive Impairments. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501139
Vancouver
Sharma S, Rai P, Maan M, Joshi S, Barman P, Sharma S, et al. Neuroprotective Role of Synthetic Peptide DP1 in Reducing Inflammation‐Associated Brain Damage and Cognitive Impairments. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202501139
BibTeX
@article{Sharma2026,
author = {Sharma, Sheetal and Rai, Prachi and Maan, Mayank and Joshi, Shubhi and Barman, Panchali and Sharma, Satvika and Saini, Avneet},
title = {Neuroprotective Role of Synthetic Peptide DP1 in Reducing Inflammation‐Associated Brain Damage and Cognitive Impairments},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202501139}
}
EUVIMED